Literature DB >> 23716997

Protective effects of two Lactobacillus plantarum strains in hyperlipidemic mice.

Li-Xin Wang1, Kai Liu, Da-Wei Gao, Ji-Kui Hao.   

Abstract

AIM: To investigate the effects of Lactobacillus plantarum (L. plantarum) CAI6 and L. plantarum SC4 on hyperlipidemic mice.
METHODS: Male Kunming mice were fed a high-cholesterol diet for 28 d to construct hyperlipidemic models. Hyperlipidemic mice and normal mice were assigned to 3 groups which were separately treated with L. plantarum CAI6, L. plantarum SC4, and physiological saline through oral gavage for 28 d. Total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) levels were measured by commercially available enzyme kits. FACS Calibur flow cytometry was used to examine hepatic and renal nuclear factor-erythroid 2-related factor 2 (Nrf2) expression. The morphology of livers was checked by hematoxylin and eosin staining and optical microscope observation.
RESULTS: Compared with normal mice, hyperlipidemic mice possessed significantly higher TC (3.50 ± 0.43 vs 2.89 ± 0.36, P < 0.01), TG (1.76 ± 0.07 vs 1.10 ± 0.16, P < 0.01), and LDL-C (1.72 ± 0.20 vs 0.82 ± 0.10, P< 0.01) levels, resulting in an increase of atherogenic index (AI) (2.34 ± 1.60 vs 0.93 ± 0.55, P < 0.05) and LDL-C/HDL-C ratio (1.43 ± 0.12 vs 0.51 ± 0.16, P < 0.05). After treatment with L. plantarum CAI6/L. plantarum SC4, TG (1.43 ± 0.27/1.54 ± 0.10 vs 1.76 ± 0.07, P < 0.01/P < 0.05) and LDL-C (1.42 ± 0.07/1.47 ± 0.12 vs 1.72 ± 0.20, P < 0.01/P < 0.01) in hyperlipidemic mice significantly decreased. In addition, TC, HDL-C, AI, and LDL-C/HDL-C ratio were all positively changed. Meanwhile, the treatment markedly alleviated hepatic steatosis and significantly stimulated Nrf2 expression (73.79 ± 0.80/72.96 ± 1.22 vs 54.94 ± 1.84, P < 0.01/P < 0.01) in hepatocytes of hyperlipidemic mice.
CONCLUSION: L. plantarum CAI6 and L. plantarum SC4 may protect against cardiovascular disease by lipid metabolism regulation and Nrf2-induced antioxidative defense in hyperlipidemic mice.

Entities:  

Keywords:  Cardiovascular disease; Hepatic steatosis; Hypolipidemic; Lactobacillus plantarum; Metabolic syndrome; Nuclear factor erythroid 2-related factor 2

Mesh:

Substances:

Year:  2013        PMID: 23716997      PMCID: PMC3662957          DOI: 10.3748/wjg.v19.i20.3150

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

Review 1.  Regulatory mechanisms of cellular response to oxidative stress.

Authors:  K Itoh; T Ishii; N Wakabayashi; M Yamamoto
Journal:  Free Radic Res       Date:  1999-10

2.  The metabolic syndrome--a new worldwide definition.

Authors:  K George M M Alberti; Paul Zimmet; Jonathan Shaw
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

3.  Bile salt and acid tolerance of Lactobacillus rhamnosus strains isolated from Parmigiano Reggiano cheese.

Authors:  M Succi; P Tremonte; A Reale; E Sorrentino; L Grazia; S Pacifico; R Coppola
Journal:  FEMS Microbiol Lett       Date:  2005-03-01       Impact factor: 2.742

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Enzymatic determination of total serum cholesterol.

Authors:  C C Allain; L S Poon; C S Chan; W Richmond; P C Fu
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

Review 6.  New insights into the regulation of HDL metabolism and reverse cholesterol transport.

Authors:  Gary F Lewis; Daniel J Rader
Journal:  Circ Res       Date:  2005-06-24       Impact factor: 17.367

Review 7.  Atherosclerosis.

Authors:  A J Lusis
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

8.  A peroxidase-coupled method for the colorimetric determination of serum triglycerides.

Authors:  M W McGowan; J D Artiss; D R Strandbergh; B Zak
Journal:  Clin Chem       Date:  1983-03       Impact factor: 8.327

Review 9.  Range of serum cholesterol values in the population developing coronary artery disease.

Authors:  W B Kannel
Journal:  Am J Cardiol       Date:  1995-09-28       Impact factor: 2.778

10.  Investigation of hypoglycemic, hypolipidemic and antioxidant activities of aqueous extract of Terminalia paniculata bark in diabetic rats.

Authors:  Subramaniam Ramachandran; Aiyalu Rajasekaran; K T Manisenthilkumar
Journal:  Asian Pac J Trop Biomed       Date:  2012-04
View more
  20 in total

1.  Lactobacillus plantarum FRT10 alleviated high-fat diet-induced obesity in mice through regulating the PPARα signal pathway and gut microbiota.

Authors:  Hongying Cai; Zhiguo Wen; Xiumei Li; Kun Meng; Peilong Yang
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-14       Impact factor: 4.813

Review 2.  Gut microbiota and metabolic syndrome.

Authors:  Davide Festi; Ramona Schiumerini; Leonardo Henry Eusebi; Giovanni Marasco; Martina Taddia; Antonio Colecchia
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

3.  Protecting Effect of Bacillus coagulans T242 on HT-29 Cells Against AAPH-Induced Oxidative Damage.

Authors:  Xiaoxi Gao; Yuhong Zhang; Guangqing Mu; Yunpeng Xu; Xinmiao Wang; Yanfeng Tuo; Fang Qian
Journal:  Probiotics Antimicrob Proteins       Date:  2022-05-02       Impact factor: 4.609

4.  Profiles of gut microbiota in obese-insulin-resistant rats treated with biotics.

Authors:  Sirawit Sriwichaiin; Weerayuth Kittichotirat; Titikorn Chunchai; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  Eur J Nutr       Date:  2022-02-23       Impact factor: 4.865

Review 5.  New perspectives of Lactobacillus plantarum as a probiotic: The gut-heart-brain axis.

Authors:  Yen-Wenn Liu; Min-Tze Liong; Ying-Chieh Tsai
Journal:  J Microbiol       Date:  2018-08-23       Impact factor: 3.422

Review 6.  Gut microbiota and obesity.

Authors:  Philippe Gérard
Journal:  Cell Mol Life Sci       Date:  2015-10-12       Impact factor: 9.261

7.  Hypocholesterolemic effects of Kluyveromyces marxianus M3 isolated from Tibetan mushrooms on diet-induced hypercholesterolemia in rat.

Authors:  Yuanhong Xie; Hongxing Zhang; Hui Liu; Lixia Xiong; Xiuzhi Gao; Hui Jia; Zhengxing Lian; Nengsheng Tong; Tao Han
Journal:  Braz J Microbiol       Date:  2015-06-01       Impact factor: 2.476

8.  Comparative study of probiotic effects of Lactobacillus and Bifidobacteria strains on cholesterol levels, liver morphology and the gut microbiota in obese mice.

Authors:  Rostyslav V Bubnov; Lidiia P Babenko; Liudmyla M Lazarenko; Viktoria V Mokrozub; Oleksandr A Demchenko; Oleksiy V Nechypurenko; Mykola Ya Spivak
Journal:  EPMA J       Date:  2017-10-10       Impact factor: 6.543

9.  Effects of the Cistanche tubulosa Aqueous Extract on the Gut Microbiota of Mice with Intestinal Disorders.

Authors:  Xiaowei Bao; Dongwen Bai; Xiaolu Liu; Ying Wang; Lanjun Zeng; Chenye Wei; Weiquan Jin
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-14       Impact factor: 2.629

Review 10.  Non-alcoholic fatty liver disease, diet and gut microbiota.

Authors:  Carmine Finelli; Giovanni Tarantino
Journal:  EXCLI J       Date:  2014-05-07       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.